155 related articles for article (PubMed ID: 35364298)
1. The Influence of Select Medications on Prospective Hemorrhage Risk in Patients with Spinal or Cerebral Cavernous Malformations.
Previch L; Lanzino G; Brown RD; Flemming KD
World Neurosurg; 2022 Jul; 163():e678-e683. PubMed ID: 35364298
[TBL] [Abstract][Full Text] [Related]
2. Predictors of Initial Presentation with Hemorrhage in Patients with Cavernous Malformations.
Flemming KD; Kumar S; Brown RD; Lanzino G
World Neurosurg; 2020 Jan; 133():e767-e773. PubMed ID: 31605843
[TBL] [Abstract][Full Text] [Related]
3. Cavernous Malformation Hemorrhagic Presentation at Diagnosis Associated with Low 25-Hydroxy-Vitamin D Level.
Flemming KD; Kumar S; Brown RD; Singh RJ; Whitehead K; McCreath L; Lanzino G
Cerebrovasc Dis; 2020; 49(2):216-222. PubMed ID: 32348981
[TBL] [Abstract][Full Text] [Related]
4. Natural history of brainstem cavernous malformations: prospective hemorrhage rate and adverse factors in a consecutive prospective cohort.
Li D; Wu ZY; Liu PP; Ma JP; Huo XL; Wang L; Zhang LW; Wu Z; Zhang JT
J Neurosurg; 2020 Mar; 134(3):917-928. PubMed ID: 32168479
[TBL] [Abstract][Full Text] [Related]
5. Association Between Beta-Blocker or Statin Drug Use and the Risk of Hemorrhage From Cerebral Cavernous Malformations.
Zuurbier SM; Hickman CR; Rinkel LA; Berg R; Sure U; Al-Shahi Salman R;
Stroke; 2022 Aug; 53(8):2521-2527. PubMed ID: 35410492
[TBL] [Abstract][Full Text] [Related]
6. Clinical presentation, hemorrhage risk, and outcome in patients with familial cavernous malformations: a pragmatic prospective analysis of 75 patients.
Alalfi MO; Lanzino G; Flemming KD
J Neurosurg; 2023 Oct; 139(4):1018-1024. PubMed ID: 36933254
[TBL] [Abstract][Full Text] [Related]
7. Antithrombotic Therapy in Cerebral Cavernous Malformations: A Systematic Review, Meta-Analysis, and Network Meta-Analysis.
Musmar B; Salim H; Abdelgadir J; Spellicy S; Adeeb N; Zomorodi A; Friedman A; Awad I; Jabbour PM; Hasan DM
J Am Heart Assoc; 2024 Mar; 13(6):e032910. PubMed ID: 38471833
[TBL] [Abstract][Full Text] [Related]
8. The Influence of Physical Activity on Cavernous Malformation Hemorrhage.
Joseph NK; Kumar S; Lanzino G; Flemming KD
J Stroke Cerebrovasc Dis; 2020 Apr; 29(4):104629. PubMed ID: 32147026
[TBL] [Abstract][Full Text] [Related]
9. Influence of Pregnancy on Hemorrhage Risk in Women With Cerebral and Spinal Cavernous Malformations.
Joseph NK; Kumar S; Brown RD; Lanzino G; Flemming KD
Stroke; 2021 Jan; 52(2):434-441. PubMed ID: 33493052
[TBL] [Abstract][Full Text] [Related]
10. Long-term antithrombotic therapy and risk of intracranial haemorrhage from cerebral cavernous malformations: a population-based cohort study, systematic review, and meta-analysis.
Zuurbier SM; Hickman CR; Tolias CS; Rinkel LA; Leyrer R; Flemming KD; Bervini D; Lanzino G; Wityk RJ; Schneble HM; Sure U; Al-Shahi Salman R;
Lancet Neurol; 2019 Oct; 18(10):935-941. PubMed ID: 31401075
[TBL] [Abstract][Full Text] [Related]
11. Use of antithrombotic agents in patients with intracerebral cavernous malformations.
Flemming KD; Link MJ; Christianson TJ; Brown RD
J Neurosurg; 2013 Jan; 118(1):43-6. PubMed ID: 22998055
[TBL] [Abstract][Full Text] [Related]
12. Are there differences in clinical presentation, radiologic findings, and outcomes in female patients with cavernous malformation?
Flemming KD; Lanzino G
Acta Neurochir (Wien); 2023 Jul; 165(7):1855-1861. PubMed ID: 37306819
[TBL] [Abstract][Full Text] [Related]
13. Impact of Long-Term Antithrombotic and Statin Therapy on the Clinical Outcome in Patients with Cavernous Malformations of the Central Nervous System: A Single-Center Case Series of 428 Patients.
Wildi S; Nager S; Akeret K; Özkaratufan S; Krayenbühl N; Bozinov O; Regli L; Velz J
Cerebrovasc Dis; 2023; 52(6):634-642. PubMed ID: 36944322
[TBL] [Abstract][Full Text] [Related]
14. Bleeding Risk of Cerebral Cavernous Malformations in Patients on Statin and Antiplatelet Medication: A Cohort Study.
Marques LL; Jaeggi C; Branca M; Raabe A; Bervini D; Goldberg J
Neurosurgery; 2023 Sep; 93(3):699-705. PubMed ID: 36999926
[TBL] [Abstract][Full Text] [Related]
15. Hemorrhage risks and functional outcomes of untreated brainstem cavernous malformations.
Li D; Hao SY; Jia GJ; Wu Z; Zhang LW; Zhang JT
J Neurosurg; 2014 Jul; 121(1):32-41. PubMed ID: 24785325
[TBL] [Abstract][Full Text] [Related]
16. Clinical course of untreated thalamic cavernous malformations: hemorrhage risk and neurological outcomes.
Tian KB; Zheng JJ; Ma JP; Hao SY; Wang L; Zhang LW; Wu Z; Zhang JT; Li D
J Neurosurg; 2017 Sep; 127(3):480-491. PubMed ID: 27834594
[TBL] [Abstract][Full Text] [Related]
17. Female Hormone Therapy and Risk of Intracranial Hemorrhage From Cerebral Cavernous Malformations: A Multicenter Observational Cohort Study.
Zuurbier SM; Santos AN; Flemming KD; Schmidt B; Jabbarli R; Lanzino G; Sure U; Dammann P
Neurology; 2023 Apr; 100(16):e1673-e1679. PubMed ID: 36754635
[TBL] [Abstract][Full Text] [Related]
18. Five-year symptomatic hemorrhage risk of untreated brainstem cavernous malformations in a prospective cohort.
Kong L; Ma XJ; Xu XY; Liu PP; Wu ZY; Zhang LW; Zhang JT; Wu Z; Wang L; Li D
Neurosurg Rev; 2022 Aug; 45(4):2961-2973. PubMed ID: 35633420
[TBL] [Abstract][Full Text] [Related]
19. Symptomatic Cavernous Malformation Presenting with Seizure without Hemorrhage: Analysis of Factors Influencing Clinical Presentation.
Agosti E; Flemming KD; Lanzino G
World Neurosurg; 2019 Sep; 129():e387-e392. PubMed ID: 31132505
[TBL] [Abstract][Full Text] [Related]
20. Hemorrhage from cerebral cavernous malformations: a systematic pooled analysis.
Gross BA; Du R
J Neurosurg; 2017 Apr; 126(4):1079-1087. PubMed ID: 27203143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
